Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-26

Clinical Trial Update: Venlafaxine in Preventing Chronic Oxaliplatin-Induced Neuropathy In Patients Receiving Combination Chemotherapy [NA]

View source ↗

Summary

Clinical trial update on venlafaxine for preventing chronic oxaliplatin-induced neuropathy in patients receiving combination chemotherapy has completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Venlafaxine (Venlafaxine)

Snippet

Sponsor: Mayo Clinic | Conditions: Peripheral Neuropathy | NA | Status: COMPLETED | Results posted: 2019-09-26